Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the Progesterone Receptor (PR) Test Immunohistochemistry is typically 3-5 business days.

What are the prerequisites for the test Progesterone Receptor (PR) Test Immunohistochemistry

  • Tissue sample fixed in 10% neutral buffered formalin
  • Paraffin-embedded tissue blocks
  • Microtome for cutting tissue sections
  • Antigen retrieval solution
  • Primary antibody against Progesterone Receptor
  • Secondary antibody conjugated with a detection system
  • Microscope for visualization

What are the measure values for the test Progesterone Receptor (PR) Test Immunohistochemistry

  • Positive: Nuclear staining in tumor cells
  • Negative: Absence of nuclear staining in tumor cells
  • Percentage of positive tumor cells
  • Intensity of staining in positive tumor cells (weak, moderate, strong)

What does this test Progesterone Receptor (PR) Test Immunohistochemistry identify?

This test identifies the presence of progesterone receptors in cells. Progesterone receptors are proteins found inside cells that bind to the hormone progesterone. By identifying the presence of progesterone receptors through immunohistochemistry, this test can help determine if a tumor is likely to respond to hormone therapy targeting progesterone receptors.

Why is this test Progesterone Receptor (PR) Test Immunohistochemistry taken?

Progesterone Receptor (PR) Test Immunohistochemistry

The Progesterone Receptor (PR) Test Immunohistochemistry is taken to determine the presence of progesterone receptors in breast cancer cells. This test is important because it helps in predicting the response of breast cancer to hormonal therapy. If the breast cancer cells have progesterone receptors, it means that they may respond well to treatments that target these receptors, such as hormone therapy.

Progesterone receptors are proteins found inside some cells, including breast cancer cells. The presence of progesterone receptors can indicate how likely a breast cancer is to respond to hormonal therapy. The PR test is usually performed on a sample of breast tissue removed during a biopsy or surgery.

Overall, the Progesterone Receptor (PR) Test Immunohistochemistry is an important tool in the management of breast cancer, as it helps in determining the most effective treatment options for patients with hormone receptor-positive breast cancer.

No FAQs available.

Customer Google Rating